Regeneron Pharmaceuticals
REGN
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabeti…
Power Profile
Earnings Counter
Regeneron Pharmaceuticals earns $142.85/sec net profit (TTM: $4.50B)
Earnings counterWhat If Invested
See what $1,000 invested in Regeneron Pharmaceuticals would be worth today
What if investedHow it makes money
Visual revenue breakdown: how Regeneron Pharmaceuticals generates income and where it flows
How it makes moneySeasonality
Monthly and quarterly returns heatmap, seasonality matrix for Regeneron Pharmaceuticals
View seasonality